ChemoMetec A/SChemoMetec A/SChemoMetec A/S

ChemoMetec A/S

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.62 B‬EUR
1.45EUR
‪24.93 M‬EUR
‪66.27 M‬EUR
‪16.76 M‬
Beta (1Y)
0.35
Employees (FY)
170
Change (1Y)
−4 −2.30%
Revenue / Employee (1Y)
‪389.84 K‬EUR
Net income / Employee (1Y)
‪146.63 K‬EUR

About ChemoMetec A/S


CEO
Martin Helbo Behrens
Headquarters
Allerod
Founded
1997
ISIN
DK0060055861
FIGI
BBG00N8DVTQ6
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1997 and is headquartered in Allerod, Denmark.

Check out other big names from the same industry as CHY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.06%
Market value
‪6.00 M‬
USD
VSS
Vanguard FTSE All-World ex-US Small-Cap ETF
Weight
0.04%
Market value
‪4.60 M‬
USD
SCHC
Schwab International Small-Cap Equity ETF
Weight
0.08%
Market value
‪3.90 M‬
USD
DFIS
Dimensional International Small Cap ETF
Weight
0.09%
Market value
‪3.41 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
0.01%
Market value
‪3.36 M‬
USD
2B78
iShares Healthcare Innovation UCITS ETF
Weight
0.23%
Market value
‪2.32 M‬
USD
EDEN
iShares MSCI Denmark ETF
Weight
1.09%
Market value
‪2.14 M‬
USD
GWX
SPDR S&P International Small Cap ETF
Weight
0.15%
Market value
‪1.21 M‬
USD
IEUR
iShares Core MSCI Europe ETF
Weight
0.01%
Market value
‪979.79 K‬
USD
DLS
WisdomTree International SmallCap Dividend Fund
Weight
0.08%
Market value
‪864.59 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of CHY is 92.25 EUR — it has decreased by −1.97% in the past 24 hours. Watch ChemoMetec A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ChemoMetec A/S stocks are traded under the ticker CHY.
CHY stock has risen by 11.08% compared to the previous week, the month change is a 28.04% rise, over the last year ChemoMetec A/S has showed a 85.46% increase.
We've gathered analysts' opinions on ChemoMetec A/S future price: according to them, CHY price has a max estimate of 97.56 EUR and a min estimate of 88.20 EUR. Watch CHY chart and read a more detailed ChemoMetec A/S stock forecast: see what analysts think of ChemoMetec A/S and suggest that you do with its stocks.
CHY reached its all-time high on Sep 24, 2021 with the price of 150.70 EUR, and its all-time low was 0.10 EUR and was reached on Dec 19, 2008. View more price dynamics on CHY chart.
See other stocks reaching their highest and lowest prices.
CHY stock is 2.01% volatile and has beta coefficient of 0.35. Track ChemoMetec A/S stock price on the chart and check out the list of the most volatile stocks — is ChemoMetec A/S there?
Today ChemoMetec A/S has the market capitalization of ‪1.62 B‬, it has increased by 9.55% over the last week.
Yes, you can track ChemoMetec A/S financials in yearly and quarterly reports right on TradingView.
ChemoMetec A/S is going to release the next earnings report on Feb 4, 2026. Keep track of upcoming events with our Earnings Calendar.
CHY earnings for the last half-year are 0.63 EUR per share, whereas the estimation was 0.68 EUR, resulting in a −7.22% surprise. The estimated earnings for the next half-year are 0.94 EUR per share. See more details about ChemoMetec A/S earnings.
ChemoMetec A/S revenue for the last half-year amounts to ‪32.63 M‬ EUR, despite the estimated figure of ‪32.63 M‬ EUR. In the next half-year revenue is expected to reach ‪37.00 M‬ EUR.
CHY net income for the last half-year is ‪11.11 M‬ EUR, while the previous report showed ‪13.82 M‬ EUR of net income which accounts for −19.62% change. Track more ChemoMetec A/S financial stats to get the full picture.
Yes, CHY dividends are paid annually. The last dividend per share was 0.53 EUR. As of today, Dividend Yield (TTM)% is 0.58%. Tracking ChemoMetec A/S dividends might help you take more informed decisions.
ChemoMetec A/S dividend yield was 1.20% in 2025, and payout ratio reached 65.35%. The year before the numbers were 1.31% and 51.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 8, 2025, the company has 170 employees. See our rating of the largest employees — is ChemoMetec A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ChemoMetec A/S EBITDA is ‪33.12 M‬ EUR, and current EBITDA margin is 49.98%. See more stats in ChemoMetec A/S financial statements.
Like other stocks, CHY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ChemoMetec A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ChemoMetec A/S technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ChemoMetec A/S stock shows the strong buy signal. See more of ChemoMetec A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.